Alternative ways of insulin application

Czech version

Authors: Rid Dravecká
Authors‘ workplace: I. interná klinika LF UPJŠ a UNLP Košice
Published in: Forum Diab 2021; 10(2): 129-135
Category:

Overview

The insulin pump treatment in patients with type 1 diabetes has a beneficial effect on improvement of their metabolic control and quality of life. The current pumps are reliable, small and light, and are becoming more and more sophisticated. Development in insulin pump technology simplifies the technical aspects of using this device. Implanted insulin pumps and tubeless patch pumps enhance patient´s comfort. Subcutaneous injection as the traditional insulin administration in the diabetes treatment is for many patients inconvenient and painful. Smart glucose- responsive insulin delivery systems could be the promising solutions.

Keywords:

implanted insulin pump – smart glucose-responsive insulin delivery system – tubeless patch pump

Sources

1. Schaepelynck P, Darmon P, Molines L et al. Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps. Diabetes Metab 2011; 37(Suppl 4): S85–93. Dostupné z DOI: <http://dx.doi.org/10.1016/S1262–3636(11)70972–7>.

2. Gonzales W, Mobashsher AT, Abbosh A. The Progress of Glucose Monitoring – A Review of Invasive to Minimally and Non-Invasive Techniques, Devices and Sensors. Sensors (Basel) 2019; 19(4): 800). Dostupné z DOI: <http://dx.doi.org/10.3390/s19040800>.

3. Patch Insulin Pump System Instruction Manual. Dostupné z WWW: <https://agentek.co.il/media/wysiwyg/Microtech/Manual_Eng.pdf>.

4. Friedman SH. Replacing Pumps with Light Controlled Insulin Delivery. Current Diabetes Reports. 2020; 19(11):122. Dostupné z DOI: <http://dx.doi.org/10.1007/s11892–019–1233–3>.

5. Wang J, Wang Z, Yu J et al. Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation. Adv Mater 2020; 32(13): e1902004. Dostupné z DOI: <http://dx.doi.org/10.1002/adma.201902004>.

6. Jain PK, Karunakaran D, Friedman SH. Construction of a Photoactivated Insulin Depot. Angew Chem Int Ed Engl 2013; 52(5): 1404–1409. Dostupné z DOI: <http://dx.doi.org/10.1002/anie.201207264>.

7. Shen D, Yu H, Wang L et al. Recent progress in design and preparation of glucose-responsive insulin delivery systems. J Control Release 2020; 321: 236–258. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jconrel.2020.02.014>.

8. Zhang Y, Yu J, Kahkoska AR et al. Advances in transdermal insulin delivery. Adv Drug Deliv Rev 2019; 139: 51–70. Dostupné z DOI: <http://dx.doi.org/10.1016/j.addr.2018.12.006>.

9. Taraghdari ZB, Imani R, Mohabatpour F. A Review on Bioengineering Approaches to Insulin Delivery: A Pharmaceutical and Engineering Perspective. Macromol Biosci 2019; 19(4): e1800458. Dostupné z DOI: <http://dx.doi.org/10.1002/mabi.201800458>.

10. Easa N, Alany RG, Carew M et al. A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade. Drug Discov Today 2019; 24(2): 440–451. Dostupné z DOI: <http://dx.doi.org/10.1016/j.drudis.2018.11.010>.

11. Chu LY. Controlled release systems for insulin delivery. Expert Opin Ther Pat 2005; 15(9): 1147–1155. Dostupné z DOI: <https://doi.org/10.1517/13543776.15.9.1147>.

12. Chen Z, Wang J, Sun W et al. Synthetic beta cells for fusion-mediated dynamic insulin secretion. Nat Chem Biol 2018; 14(1): 86–93. Dostupné z DOI: <http://dx.doi.org/10.1038/nchembio.2511>.

13. Vettoretti M, Facchinetti A. Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review. Biomed Eng Online 2019; 18(1): 37. Dostupné z DOI: <http://dx.doi.org/10.1186/s12938–019–0658-x>.

14. Lee H, Hong YJ, Seungmin Baik S et al. Enzyme-Based Glucose Sensor: From Invasive to Wearable Device. Adv Healthc Mater 2018; 7(8): e1701150. Dostupné z DOI: <http://dx.doi.org/10.1002/adhm.201701150>.